Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -106,195 | -7,937 | -37,127 | -29,372 | -19,920 |
| Depreciation Amortization | 128 | 64 | 272 | 206 | 136 |
| Accounts payable and accrued liabilities | 2,289 | 215 | -2,731 | -1,955 | -2,142 |
| Other Working Capital | 2,552 | 430 | -8,327 | -3,816 | -2,907 |
| Other Operating Activity | 86,830 | 1,733 | 10,227 | 7,431 | 5,559 |
| Operating Cash Flow | $-14,398 | $-5,495 | $-37,686 | $-27,507 | $-19,274 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 1,747 | 87 | N/A |
| Financing Cash Flow | $0 | $0 | $1,747 | $87 | $N/A |
| Exchange Rate Effect | 384 | 71 | -3 | -169 | 60 |
| Beginning Cash Position | 53,076 | 53,076 | 89,018 | 89,018 | 89,018 |
| End Cash Position | 39,062 | 47,652 | 53,076 | 61,428 | 69,804 |
| Net Cash Flow | $-14,014 | $-5,424 | $-35,942 | $-27,589 | $-19,214 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,398 | -5,495 | -37,686 | -27,507 | -19,274 |
| Free Cash Flow | -14,398 | -5,495 | -37,686 | -27,507 | -19,274 |